Skip to main content
James R Wilentz, MD, Cardiology, New York, NY

James R Wilentz MD FACC, FSCAI

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology


Associate Clinical Professor Global Health, Mount Sinai School of Medicine, Arnhold Institute of Global Health

Join to view full profile
  • 10 Union Sq. ESte 2BNew York, NY 10003

  • Phone+1 212-844-8830

  • Fax+1 212-844-8831

Dr. Wilentz is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. James R Wilentz is a global health educator and cardiologist based in New York, NY. He is no longer seeing patients clinically. He has specializied in Interventional Cardiology, Peripheral Endovascular Intervention. and has had an interest in Adult Congenital Heart Disease. He completed his medical education at New York University School of Medicine, followed by residency at Brigham and Women's Hospital and fellowships at institutions including Boston University Medical Center and Emory University School of Medicine. He holds academic positions as an Associate Clinical Professor at Icahn School of Medicine at Mount Sinai. Dr. Wilentz has been engaged in research, evidenced by publications in journals such as the Journal of the American College of Cardiology. He has participated in the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial. His honors include recognition as a Regional Top Doctor and Fellow of the American Heart Association.

Education & Training

  • Emory University School of Medicine
    Emory University School of Medicine1985 - 1986
  • Boston University Medical Center
    Boston University Medical CenterFellowship, Cardiovascular Disease, 1982 - 1984
  • Harvard College
    Harvard CollegeFellowship, Internal Medicine, 1980 - 1982
  • Peter Bent Brigham Hospital
    Peter Bent Brigham Hospital1979 - 1982
  • Harvard College
    Harvard CollegeFellowship, Internal Medicine, 1976 - 1980

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1986 - 2028
  • NJ State Medical License
    NJ State Medical License 1999 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly
  • NY Magazine/Castle Connolly Top Doctor Interventional Cardiology NY Magazine/Castle Connolly
  • Fellow FAHA American Heart Association

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Population health and sociodemographic variables as predictors of access to cardiac medicine and surgery in Haiti  
    Bansal E, Patel K, Lacossade S, Gue B, Acceme K, Robinson O, Kwan GF, Wilentz JR, BMC Global Health Research and Policy, 7/19/2023
  • Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial.  
    Fuchs J Cannon CP for the TIMI 7 Investigators (Wilentz JR Principal Investigator, Circulation
  • Mid-term results and patient perceptions of robotically-assisted coronary artery bypass grafting.  
    DeRose JJ Jr, Balaram SK, Ro C, Swistel DG, Singh V, Wilentz JR, Todd GJ, Ashton RC Jr, Interactive Cardiovascular and Thoracic Surgery

Books/Book Chapters

Abstracts/Posters

  • Bailout Stenting for Abrupt Closure During Coronary Angioplasty.
    Meckel CR Kjelsberg MA Ahmed WH Ganz P Piana RN Deutsch E Strony J Bittl JA Hirulog Angioplasty Study Investigators, Circulation
  • Coronary Flow Reserve By Doppler Wire is NotEquivalent to Stenotic Flow Reserve.
    Lieberman SM, Undemir C, Shaknovich A, Wilentz JR, Friedman MS, Higgins J, CohenNT, McCrossen J, Moses JW, Circulation
  • Clinical Evidence for Thrombin Rebound After Stopping Heparin but not Hirulog.
    Strony J Ahmed WH Meckel CR Maraganore J Adelman B Bittl JA, Hirulog Angioplasty Study Investigators, Circulation 1995 92: I-609

Other

  • Primary PTCA in Acute Myocardial Infarction. 
    Block PC Ghazzal Z Wilentz JR, Video Presentation
    American College of Cardiology Heart House Learning Center Video Round Table

Professional Memberships

Other Languages

  • French

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: